Phthalocyanine-nanoparticle conjugates for enhanced cancer photodynamic therapy | Synapse
January 1, 2025Open Access
Phthalocyanine-nanoparticle conjugates for enhanced cancer photodynamic therapy
Key Points
Enhanced cell death occurs due to increased production of reactive oxygen species (ROS) during photodynamic therapy.
Key evidence shows that the utilization of phthalocyanine-nanoparticle conjugates greatly improves cancer treatment outcomes.
The approach focuses on the innovative use of photodynamic therapy to activate photosensitizers and eradicate tumor cells.
These findings may enable improved cancer treatment strategies using minimally invasive techniques with targeted effects.
Abstract
Photodynamic therapy (PDT) represents a selective and minimally invasive strategy for cancer treatment, relying on light-activated photosensitizers (PSs) to produce ROS that induce tumor cell death.